Skip to content

Effectiveness of Flash Mediation Therapy

Study on Effectiveness of Flash Mediation Therapy in the Context of Acute Psychological and Behavioral Symptoms of Dementia in Nursing Homes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02933177
Enrollment
241
Registered
2016-10-14
Start date
2016-05-31
Completion date
2017-03-31
Last updated
2017-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Keywords

Dementia, Alzheimer disease, Behavioral and Psychological Symptoms of Dementia, non-drug intervention

Brief summary

In order to offer a non-drug intervention for caregivers in nursing home to respond promptly to a behavioral crisis with an appropriate response to each patient, a chariot has been developed by the Institute of Ageing Well Korian (Institut du Bien Vieillir Korian) to bring together eleven mediation activities. These activities lasting about 15 minutes are based on emotion (reminiscent, games) and sensory interventions (music, massage, touch) to decentralize patient stimulus that disturbs and focus on a subject not disruptive. This emergency intervention should provide a reduction in Behavioral and Psychological Symptom of Dementia (BPSD) of nursing home patients. The main objective is to measure its immediate effect on productive symptoms (agitation, aberrant motor behavior and disinhibition). The secondary objectives are to measure its immediate impact on the well-being and psychotropic treatments, and measure its effect after two months and after four months on all BPSD with a focus on agitation, the administration of psychotropic drugs, the hospitalizations and the number of falls.

Interventions

BEHAVIORAL2 months control condition - 4 months chariot-flash

The control condition is to propose the usual procedures for the management of productive symptoms during the emergence or increase of these symptoms. The chariot-flash condition is a chariot with eleven drawers. Each drawer contains an activity (lasting about 15 minutes): * Boards of known photographs to recall autobiographical memories * Newspapers to read, talk, associate memories around an article * Massage Oil, refreshing wipes, cream to reconnect with the body * Clay, cookie pieces, washable felt and paper to create shapes, draw. * Walk with a person of the healthcare team the case of behavioral disorders in type of ambulation and untimely exit . * Listening to music * Relaxation-Breathing * Cushion, foam balls to vent his energy on secure hardware. * Plush doll or to invest a vector object of affection and empathy * Sensory flash balls that the patient can squeeze, throw, roll. * Games with which the patient can play according to its possibilities.

BEHAVIORAL4 months control condition-2 months chariot flash

The control condition is to propose the usual procedures for the management of productive symptoms during the emergence or increase of these symptoms. The chariot-flash condition is a chariot with eleven drawers. Each drawer contains an activity (lasting about 15 minutes): * Boards of known photographs to recall autobiographical memories * Newspapers to read, talk, associate memories around an article * Massage Oil, refreshing wipes, cream to reconnect with the body * Clay, cookie pieces, washable felt and paper to create shapes, draw. * Walk with a person of the healthcare team the case of behavioral disorders in type of ambulation and untimely exit . * Listening to music * Relaxation-Breathing * Cushion, foam balls to vent his energy on secure hardware. * Plush doll or to invest a vector object of affection and empathy * Sensory flash balls that the patient can squeeze, throw, roll. * Games with which the patient can play according to its possibilities.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* People ability to object and does not oppose either by themselves or through a trusted person referred to in Article L. 1111-6 of the Code of Public Health, failing thereof, by the family, or, if a person talking to the person close and stable ties. For adults under guardianship, permission must be given by the legal representative of the person. The research will benefit from the backing of Persons Protection Committee (PPC) prior to its implementation; * Man or woman over 60 years; * patient living in one of the nursing homes participating in the project; * Patient completing the diagnostic criteria for major neurocognitive disorder according to Diagnostic and Statistical Manual of Mental Disorders V criteria (DSM-V) * The patient must have at least one of these productive symptoms (agitation, aberrant motor behavior, disinhibition) listed by the NPI-NH (score\> 2 at least one of these items)

Exclusion criteria

* Deafness or blindness may compromise patient assessment or participation in the intervention

Design outcomes

Primary

MeasureTime frameDescription
Change in number of disordersuntil 4 monthsthe number of disorders are evaluated with Cohen Mansfield Agitation Inventory (CMAI) before and 30 minutes after each intervention. The original version of the CMAI is initially planned to study the frequency of these disorders. However, the goal being to study the decrease in productive symptoms, after using the chariot-flash, only the number of this item will be considered (between 0 and 29). For example in this modified version, for the item pace, aimless wandering nursing team can answer present or absent instead of (never, less than once a week, once or twice per week, a few times over week, one to two times daily, several times a day, several times per hour)

Secondary

MeasureTime frameDescription
change in psychotropic drugs prescribeduntil 4 monthsThe caregiver or doctor will check on a board what are the treatments that have been added or modified (compared to the usual treatment) in response to behavioral disorder
change in score of BPSDbefore the beginning of the study, at 2 months, 4 months and 6 monthsthe score of BPSD is assessed using the neuropsychiatric inventory nursing home version (NPI-NH). Each of the 12 BPSD (delusions, hallucinations, agitation, depression, anxiety, excitement, apathy, disinhibition, depression, motor aberrant behavior, sleep and appetite) is evaluated on 12 depending on its frequency and severity (global score =144).
change in level of agitationbefore the beginning of the study, at 2 months, 4 months and 6 monthsthe level of agitation is assessed using the original version of CMAI. The CMAI lists 29 agitation and aggressive behaviors by frequency (0: not evaluable 1: never, 2: less than once a week 3 : once or twice per week, 4 : a few times over week, 5: one to two times daily, 6 : several times a day, 7 : several times per hour) to obtain a score ranging from 0-203.
Change in score of well-beinguntil 4 monthsthe score of well-being is assessed using the Instant Well-Being scale (Evaluation Instantané du Bien-Etre : EVIBE) before and 30 minutes after each intervention . The EVIBE is a visual analogue scale for reporting the status of well-being of the patient at a specific time. On a graduated scale from 0 to 5, the caregiver should position a cursor position to the left corresponding to the feeling of well-being the lowest and the right position to the feeling of well-being the highest.
The number of hospitalizationat 2 months, 4 months and 6 monthsThe caregiver or doctor will refer in a table the different hospitalizations during the study and their date
The number of fallat 2 months, 4 months and 6 monthsThe caregiver or doctor will refer in a table the different falls during the study and their date.
change in the number of administered psychotropic drugs.before the beginning of the study, at 2 months, 4 months and 6 monthsThe caregiver or doctor will check on a board on which is written all psychotropic treatments that the patient takes and the dosage

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026